Blog

Health Law News, Private Equity

Print PDF

Private Equity Deal Spotlight | Weekly Update

Posted on November 21, 2024 in Health Law News, Private Equity

Published by: Hall Render

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

  • 1315 Capital, a growth equity firm that specializes in health care, announced the acquisition and growth investment in SciSafe. SciSafe is a leading provider of biological and specialized pharmaceutical storage devices that focuses heavily on regulatory compliance. Following the acquisition, 1315 Capital intends to support the future growth and development of SciSafe’s bio-storage solutions. 1315 Capital is a PE firm based in Philadelphia, Pennsylvania with over $1B of assets under management that largely provides growth capital to health care services, pharmaceutical and medical technology outsourcing, medical technology and health and wellness companies.
  • Periscope Equity announced a new investment partnership with Reservoir Consulting Group. Reservoir Consulting Group is a Washington, D.C.-based health care consultancy that helps clients address business, advocacy, policy and reputational hurdles and opportunities. The investment partnership is aimed at accelerating Reservoir Consulting Group’s overall growth and scale across the country. Periscope Equity is a Chicago, Illinois-based PE firm that partners with founder-owned, technology-based business services companies throughout the United States.
  • Safecor Health, a market leader in the pharmaceutical unit-dose repackaging and supply chain solutions industry, announced the acquisition of Viatris, Inc. Viatris provides unit-dose generic medicines to institutional and long-term care facilities throughout the United States. The transaction is expected to be finalized in early 2025. Safecor Health is backed by Vesey Street Capital Partners, which is a PE firm located in New York City specializing in buyouts of lower middle-market health care services businesses.
  • H.I.G. Growth Partners announced a growth equity investment in Carebox. Carebox is a leading health care software platform that partners with over 40 leading life science firms, research organizations and foundations that aim to connect patients, families and physicians with potentially life-saving treatment options only available through clinical trials. H.I.G. Growth Partners is the growth capital investment affiliate of H.I.G. Capital, a global alternative investment firm with over $66B of capital under management.

If you have any questions or would like additional information, please contact:

Hall Render blog posts and articles are intended for informational purposes only. For ethical reasons, Hall Render attorneys cannot—outside of an attorney-client relationship—answer specific questions that would be legal advice.